[PERSON]
Antonio Costanzo
Featured in 1 tracked story · first seen
Situations
Upadacitinib expanded approval for skin and arthritis
4 clusters · 22 sources · last updated
Latest: European Commission approves upadacitinib for three immune-mediated diseases
Clinical trials for the Janus kinase (JAK) inhibitor upadacitinib have demonstrated success in treating severe alopecia areata by blocking inflammatory signals via the JAK/STAT pathway. Research indicates that up to 23 p